Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5569648 | The Journal for Nurse Practitioners | 2017 | 9 Pages |
Abstract
Testosterone replacement therapy (TRT) is 1 treatment option for men with hypogonadism. When TRT is prescribed, effectiveness, patient compliance, cost, and potential side effects should be considered and used to develop an individualized treatment plan. Depo-Testosterone (Pfizer Inc, New York, NY, USA) is the most cost-efficient TRT option and is only administered every 2 weeks, which may improve patient compliance, although the dose interval can be adjusted to once per week. Androderm is the most efficacious TRT medication, with up to 92% of patients reaching normal testosterone levels. Testim (Endo Pharmaceuticals Inc, Malvern, PA, USA) and Vogelxo (Upsher-Smith Laboratories Inc, Maple Grove, MN, USA) have the fewest reported side effects. We recommend Depo-Testosterone as a first-line treatment option.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Karlen E. DNP, FNP, Chris MS, FNP, Donna S. PhD, FNP, Aaron PharmD,